Company · CIK 1828185
Barinthus Biotherapeutics plc.
| CIK | 1828185 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | X0 |
| Business address | MD |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2021-06-14 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-265763 | 2022-06-22 | 2026-09-14 | 3 | |
| 333-266724 | 2022-08-09 | 2022-08-17 | 2 | |
| 333-255158 | 2021-04-09 | 2021-04-30 | 5 |
Filings
11| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-09-14 | EFFECTDeclared effective | 333-265763 | 9999999995-26-002957 |
| 2022-08-17 | EFFECTDeclared effective | 333-266724 | 9999999995-22-002420 |
| 2022-08-09 | S-3Shelf registered | 333-266724 | 0001104659-22-088050 |
| 2022-07-07 | EFFECTDeclared effective | 333-265763 | 9999999995-22-001986 |
| 2022-06-22 | S-3Shelf registered | 333-265763 | 0001104659-22-073372 |
| 2021-04-30 | 424B4Final prospectus | 333-255158 | 0001104659-21-058759 |
| 2021-04-29 | EFFECTDeclared effective | 333-255158 | 9999999995-21-001631 |
| 2021-04-27 | S-1/AAmendment | 333-255158 | 0001104659-21-055576 |
| 2021-04-26 | S-1/AAmendment | 333-255158 | 0001104659-21-054698 |
| 2021-04-09 | S-1Registration filed | 333-255158 | 0001104659-21-048698 |
| 2020-12-23 | DRSDraft made public | 377-03949 | 0001104659-20-139201 |